Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine admi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
0
Authors
Maheshi Ramasamy
113 more
Maheshi Ramasamy
•
May Lwin
111 more
•
Daan Bormans
Published
November 19, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Internal Medicine
Pediatrics
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(20)32466-1
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Internal Medicine
Pediatrics
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(20)32466-1
License
CC-BY-NC-ND
Other Formats
PDF
